Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in lewy body disease

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 10, 2011, Pages 879-889

  Tanji, Kunikazu ^a   Mori, Fumiaki ^a   Kito, Katsumi ^b   Kakita, Akiyoshi ^c   Mimura, Junsei ^a   Itoh, Ken ^a   Takahashi, Hitoshi ^d   Kamitani, Tetsu ^e   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Center for Bioresource based Researches   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Synuclein; Dementia with Lewy bodies; NUB1; Parkinson disease; Presynapse; Proteinase K; Synphilin 1

Indexed keywords

ALPHA SYNUCLEIN; BINDING PROTEIN; PROTEIN NUB1; PROTEINASE K; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LEWY BODY; MALE; MOUSE; NEOCORTEX; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, NEWBORN; BRAIN; ENDOPEPTIDASE K; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELA CELLS; HUMANS; LEWY BODY DISEASE; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; PRESYNAPTIC TERMINALS; SYNAPTOPHYSIN; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 80053343424     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182303745     Document Type: Article

References (41)

1. Maroteaux L, Scheller RH. The rat brain synucleins: Family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res 1991;11:335-43
2. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-AA component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-75
3. Abeliovich A, Schmitz Y, Farinas I, et al. Mice lacking 〉-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000;25:239-52 (Pubitemid 30316525)
4. George JM, Jin H, Woods WS, et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995;15:361-72
5. Murphy DD, Rueter SM, Trojanowski JQ, et al. Synucleins are developmentally expressed, and 〉-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 2000;20: 3214-20 (Pubitemid 30263139)
6. Liu S, Ninan I, Antonova I, et al. 〉-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J 2004;23:4506-16 (Pubitemid 39601975)
7. Yavich L, Oksman M, Tanila H, et al. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human 〉-synuclein. Neurobiol Dis 2005;20:303-13 (Pubitemid 41476258)
8. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the 〉-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47 (Pubitemid 27443610)
9. Krüger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding 〉-synuclein in Parkinson's disease. Nat Genet 1998;18:106-8
10. Chartier-Harlin MC, Kachergus J, Roumier C, et al. 〉-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364: 1167-69 (Pubitemid 39296604)
11. Bradbury J. 〉-Synuclein gene triplication discovered in Parkinson's disease. Lancet Neurol 2003;2:715
12. Goedert M. Familial Parkinson's disease. The awakening of 〉-synuclein. Nature 1997;388:232-33
13. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of 〉-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73 (Pubitemid 38166992)
14. Spillantini MG, Schmidt ML, Lee VM, et al. 〉-synuclein in Lewy bodies. Nature 1997;388:839-40
15. Baba M, Nakajo S, Tu PH, et al. Aggregation of 〉-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84 (Pubitemid 28173348)
16. Kramer ML, Schulz-Schaeffer WJ. Presynaptic 〉-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007;27:1405-10
17. Tanji K, Mori F, Mimura J, et al. Proteinase KYresistant 〉-synuclein is deposited in presynapses in human Lewy body disease and A53T 〉-synuclein transgenic mice. Acta Neuropathol 2010;120:145-54
18. Kito K, Yeh ET, Kamitani T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem 2001;276:20603-9
19. Engelender S, Kaminsky Z, Guo X, et al. Synphilin-1 associates with 〉-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 1999;22:110-14 (Pubitemid 29214817)
20. Tanji K, Tanaka T, Mori F, et al. NUB1 suppresses the formation of Lewy bodyYlike inclusions by proteasomal degradation of synphilin-1. Am J Pathol 2006;169:553-65 (Pubitemid 44156314)
21. Wakabayashi K, Engelender S, Yoshimoto M, et al. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 2000;47: 521-23 (Pubitemid 30194611)
22. Wakabayashi K, Engelender S, Tanaka Y, et al. Immunocytochemical localization of synphilin-1, an 〉-synucleinYassociated protein, in neurodegenerative disorders. Acta Neuropathol 2002;103:209-14 (Pubitemid 36075320)
23. Tanji K, Mori F, Kakita A, et al. Immunohistochemical localization of NUB1, a synphilin-1Ybinding protein, in neurodegenerative disorders. Acta Neuropathol 2007;114:365-71 (Pubitemid 47500348)
24. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211 (Pubitemid 36007810)
25. Giasson BI, Duda JE, Quinn SM, et al. Neuronal 〉-synucleinopathy with severe movement disorder in mice expressing A53T human 〉-synuclein. Neuron 2002;34:521-33 (Pubitemid 34628750)
26. Fujiwara H, Hasegawa M, Dohmae N, et al. 〉-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-4
27. Jakes R, Crowther RA, Lee VM, et al. Epitope mapping of LB509, a monoclonal antibody directed against human 〉-synuclein. Neurosci Lett 1999;269:13-16 (Pubitemid 29305690)
28. Kamitani T, Kito K, Fukuda-Kamitani T, et al. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 2001; 276:46655-60
29. Tanji K, Kamitani T, Mori F, et al. TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis 2010;38:210-18
30. Zhang HX, Tanji K, Mori F, et al. Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci Lett 2008;434: 170-74
31. Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective 〉-synuclein nitration in synucleinopathy lesions. Science 2000;290:985-89
32. Hasegawa M, Fujiwara H, Nonaka T, et al. Phosphorylated 〉-synuclein is ubiquitinated in 〉-synucleinopathy lesions. J Biol Chem 2002;277: 49071-76 (Pubitemid 35470880)
33. Lippa CF, Fujiwara H, Mann DM, et al. Lewy bodies contain altered 〉-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70 (Pubitemid 28509891)
34. Prusiner SB, Groth DF, Bolton DC, et al. Purification and structural studies of a major scrapie prion protein. Cell 1984;38:127-34 (Pubitemid 15216542)
35. Hashimoto M, Hsu LJ, Sisk A, et al. Human recombinant NACP/〉-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res 1998;799:301-6 (Pubitemid 28351261)
36. Hashimoto M, Hsu LJ, Xia Y, et al. Oxidative stress induces amyloid-like aggregate formation of NACP/〉-synuclein in vitro. Neuroreport 1999;10: 717-21 (Pubitemid 29393812)
37. Trojanowski JQ, Lee VM. Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain. Parkinsonism Relat Disord 2001;7:247-51 (Pubitemid 32372507)
38. Hidalgo-de-Quintana J, Evans RJ, Cheetham ME, et al. The Leber congenital amaurosis protein AIPL1 functions as part of a chaperone heterocomplex. Invest Ophthalmol Vis Sci 2008;49:2878-87
39. Akey DT, Zhu X, Dyer M, et al. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1. Hum Mol Genet 2002;11:2723-33 (Pubitemid 35214899)
40. Hipp MS, Raasi S, Groettrup M, et al. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 2004;279:16503-10 (Pubitemid 38509349)
41. Tanaka T, Yeh ET, Kamitani T. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur J Biochem 2004; 271:972-82 (Pubitemid 38299651)